Product Name | Rocaglamide | Roc-A | MG-002 |
---|---|
CAS | 84573-16-0 |
Formula | C29H31NO7 |
MW | 505.56 |
Appearance | White to off-white powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
1 mg | 3-5days | $486.00 | Visible after login | |
5 mg | 3-5days | $4036.00 | Visible after login |
Product Name | Rocaglamide | Roc-A | MG-002 |
---|---|
CAS | 84573-16-0 |
Formula | C29H31NO7 |
MW | 505.56 |
Appearance | White to off-white powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Rocaglamide (Roc-A) is isolated from the genus Aglaia and can be used for coughs, injuries, asthma and inflammatory skin diseases. Rocaglamide is a potent inhibitor of NF-κB activation in T-cells. Rocaglamide is a potent and selective heat shock factor 1 (HSF1) activation inhibitor with an IC50 of ~50 nM. Rocaglamide inhibits the function of the translation initiation factor eIF4A. Rocaglamide also has anticancer properties in leukemia.
PMID: 23869022 PMCID: PMC3959726 DOI: 10.1126/science.1238303
PMID: 25333816 PMCID: PMC4237083 DOI: 10.3892/mmr.2014.2718
Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells.
PMID: 25333816 PMCID: PMC4237083 DOI: 10.3892/mmr.2014.2718